Sort
48,018 grants matching “immunotherapy”
Activated NK CAR Cells to Cure HIV
$753,478Pamela J Skinner · University Of Minnesota · R01 · FY2023 · AI
Role of gamma/delta T cells in Vaccine Induced Immunity
$753,335Daniel F. Hoft · Saint Louis University · R01 · FY2019 · AI
Molecular details of the IgE antibody response to galactose-alpha-1,3-galactose in alpha-gal syndrome
$753,304Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2025 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$753,235Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2020 · AI
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$753,094Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2025 · AI
Clinical Implications of Natural Killer-derived exosomal miRNAs in Neuroblastoma
$752,969Muller Fabbri · Children'S Research Institute · R01 · FY2024 · CA
Developing broad-spectrum therapeutics against C. difficile toxins
$752,846Rongsheng Jin · University Of California-Irvine · R01 · FY2024 · AI
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection
$752,830Yi Zhang · Hackensack University Medical Center · R01 · FY2024 · CA
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$752,351James R. Heath · Institute For Systems Biology · U54 · FY2023 · CA
T cells in the aging brain
$752,242Anne Brunet · Stanford University · R01 · FY2021 · AG
Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
$752,010Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
$751,987Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI
Attenuating Inflammation to Restore GI Tract Integrity and Reduce Viral Reservoirs During cART
$751,962Jacob D Estes · Oregon Health & Science University · R01 · FY2022 · DK
Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping
$751,954Han Zhu · Stanford University · R01 · FY2024 · HL
Baltimore Acute Hepatitis C Cooperative Center
$751,751Andrea L Cox · Johns Hopkins University · U19 · FY2012 · AI
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
$751,693Evan Michael Graboyes · Medical University Of South Carolina · R01 · FY2023 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$751,633Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Regulatory T Cells in Autoimmune Disease
$751,375David A. Hafler · Brigham And Women'S Hospital · U19 · FY2009 · AI
Neural response to inflammatory challenge in major depressive disorder
$751,094Jonathan Savitz · Laureate Institute For Brain Research · R01 · FY2021 · MH
Harnessing adaptive NK cell transfer to deplete viral reservoirs
$751,016David T Evans · University Of Wisconsin-Madison · R01 · FY2022 · AI
Integrated Multi-omics of Melioidosis
$750,994Timothy Eoin West · University Of Washington · R01 · FY2018 · AI
Baltimore Acute Hepatitis C Cooperative Center
$750,866Andrea L Cox · Johns Hopkins University · U19 · FY2014 · AI
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$750,806Suresh S Ramalingam · Emory University · UG1 · FY2020 · CA
Beta-2 adrenergic signaling in immune homeostasis and reconstitution
$750,705Xuefang Cao · University Of Maryland Baltimore · R01 · FY2024 · HL
Mitochondrial Regulation of Antitumor Immunity
$750,523Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2025 · CA